Exact Mass: 407.2308

Exact Mass Matches: 407.2308

Found 500 metabolites which its exact mass value is equals to given mass value 407.2308, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Leu-Leu-Tyr

(2S)-2-{[(2S)-2-{[(2S)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C21H33N3O5 (407.242)

Acquisition and generation of the data is financially supported in part by CREST/JST. KEIO_ID L007

Cammaconine

Aconitane-8,14-diol, 20-ethyl-4-(hydroxymethyl)-1,16-dimethoxy-, (1alpha,14alpha,16beta)-

C23H37NO5 (407.2672)

D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents > D011564 - Furocoumarins

Norerythrostachaldine

C23H37NO5 (407.2672)

FT-0701062

Ancistrocladine

C25H29NO4 (407.2096)

Geranylgeranylcysteine

(2R)-2-{[(2E,6E,10E)-1-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-ylidene]amino}-3-sulphanylpropanoic acid

C23H37NO3S (407.2494)

Geranylgeranylcysteine is a modified thioether amino acid in which an isoprenyl group (geranylgeranyl) has been attached to the sulfhydryl group of cysteine through a thioether bond. Geranylgeranylcysteine is typically formed through posttranslational (prenylation) protein modification whereupon degradation of the parent protein leaves the modified (prenylated) amino acid. Prenylation is a relatively recently discovered post-translational modification of proteins that directs cytosollic proteins to membranes while at the same time activating them functionally. The change in hydrophobicity that is essential for membrane binding is done via the covalent attachment of a polyisoprene (such as a farnesyl or geranylgeranyl group) to a C-terminal cysteine by a thioether bond. Prenylated proteins can comprise up to 2\\% of total cellular protein. Prenylcysteine lyase is an enzyme that is capable of cleaving the thiother bond in prenylcysteines and is used to help in the turnover of prenylated proteins. Prenylcysteine lyase deficiency leads to the accumulation of farnesylcysteine and geranylgeranylcysteine in brain and liver. (PMID: 9287348) [HMDB] Geranylgeranylcysteine is a modified thioether amino acid in which an isoprenyl group (geranylgeranyl) has been attached to the sulfhydryl group of cysteine through a thioether bond. Geranylgeranylcysteine is typically formed through posttranslational (prenylation) protein modification whereupon degradation of the parent protein leaves the modified (prenylated) amino acid. Prenylation is a relatively recently discovered post-translational modification of proteins that directs cytosollic proteins to membranes while at the same time activating them functionally. The change in hydrophobicity that is essential for membrane binding is done via the covalent attachment of a polyisoprene (such as a farnesyl or geranylgeranyl group) to a C-terminal cysteine by a thioether bond. Prenylated proteins can comprise up to 2\\% of total cellular protein. Prenylcysteine lyase is an enzyme that is capable of cleaving the thiother bond in prenylcysteines and is used to help in the turnover of prenylated proteins. Prenylcysteine lyase deficiency leads to the accumulation of farnesylcysteine and geranylgeranylcysteine in brain and liver. (PMID: 9287348).

Neurotensin 11-13

(2R)-2-{[(2S)-2-{[(2R)-2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxy-3-methylpentylidene]amino}-4-methylpentanoate

C21H33N3O5 (407.242)

Neurotensin is a 13 amino acid neuropeptide that is implicated in the regulation of luteinizing hormone and prolactin release and has significant interaction with the dopaminergic system. Neurotensin was first isolated from extracts of bovine hypothalamus based on its ability to cause a visible vasodilation in the exposed cutaneous regions of anesthetized rats. This structure shows the 11-13 fragment of neurotensin. Neurotensin is a 13 amino acid neuropeptide that is implicated in the regulation of luteinizing hormone and prolactin release and has significant interaction with the dopaminergic system. Neurotensin was first isolated from extracts of bovine hypothalamus based on its ability to cause a visible vasodilation in the exposed cutaneous regions of anesthetized rats

N-Arachidonoyl Cysteine

2-[(1-Hydroxyicosa-5,8,11,14-tetraen-1-ylidene)amino]-3-sulphanylpropanoic acid

C23H37NO3S (407.2494)

N-arachidonoyl cysteine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Cysteine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Cysteine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Cysteine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

4-Methyl Erlotinib Hydrochloride

N-(3-ethynyl-4-methylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine

C23H25N3O4 (407.1845)

Ancistrocladine

5-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-8-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-6-ol

C25H29NO4 (407.2096)

1,3(2H,4H)-Isoquinolinedione, 2-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-4,4-dimethyl-

2-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-4,4-dimethyl-1,2,3,4-tetrahydroisoquinoline-1,3-dione

C24H29N3O3 (407.2209)

D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists ARC 239 is an α2B/C-adrenergic receptor antagonist with pKi of 7.06 and 6.95 for rat kidney α2B and human α2C, respectively. ARC 239 also inhibits 5-HT1A receptor with a Ki of 63.1 nM[1][2].

Bidisomide, (+)-isomer

alpha-(2-(Acetyl(1-methylethyl)amino)ethyl)-alpha-(2-chlorophenyl)-1-piperidinebutanamide

C22H34ClN3O2 (407.2339)

C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

Disobutamide

4-[Bis(propan-2-yl)amino]-2-(2-chlorophenyl)-2-[2-(piperidin-1-yl)ethyl]butanimidate

C23H38ClN3O (407.2703)

C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent

PDE-4 Inhibitors

N-({2-[3-(cyclopentyloxy)-4-methoxyphenyl]-1,3-oxazol-4-yl}methyl)-3-methylpyridine-2-carboximidate

C23H25N3O4 (407.1845)

Isotalatizidine

C23H37NO5 (407.2672)

A diterpene alkaloid that is aconitane bearing hydroxy groups at the 1alpha, 8, and 14alpha positions and substituted at on the nitrogen and at positions 4 and 16beta by ethyl, methoxymethyl, and methoxy groups, respectively. Annotation level-1

N-phenyl[(9,11,13-trimethyl-8,15-dioxatetracyclo[10.2.2.0<2,7>.0<9,14>]hexadec a-2(7),3,5-trien-12-yl)methoxy]carboxamide

C25H29NO4 (407.2096)

relative retention time with respect to 9-anthracene Carboxylic Acid is 1.405 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.404

ChemDiv1_008955

C22H29N7O (407.2433)

TCMDC-125011

C21H33N3O3S (407.2243)

Feldamycin

C17H25N7O5 (407.1917)

C22H30ClNO4

C22H30ClNO4 (407.1863)

(3Z,6S)-3-{{2-(1,1-dimethylprop-2-en-1-yl)-7-[(2E)-4-hydroxy-3-methylbut-2-en-1-yl]-1H-indol-3-yl}methylidene}-6-methylpiperazine-2,5-dione|variecolorin M

C24H29N3O3 (407.2209)

lamarckinine

C22H33NO6 (407.2308)

C22H33NO6

C22H33NO6 (407.2308)

oxystemoninine

C22H33NO6 (407.2308)

C25H29NO4

C25H29NO4 (407.2096)

oxepinamide F

C23H25N3O4 (407.1845)

1-hydroxy-3,5-dimethoxy-2,4-bis-(3-methyl-but-2-enyl)-10H-acridin-9-one|atalaphylline 3,5-dimethyl ether|atalaphylline-3,5-dimethyl ether

C25H29NO4 (407.2096)

CHEMBL464197

C23H37NO5 (407.2672)

1alpha,12alpha-epoxy-20-ethyl-14alpha,16beta-dimethoxy-aconitane-4,8,9-triol|Excelsin

C22H33NO6 (407.2308)

cochinchistemoninone

C22H33NO6 (407.2308)

(3S,6S)-3-((1,7-dihydro-7,7-dimethyl-2-(2-methylbut-3-en-2-yl)pyrano[2,3-g]indol-3-yl)methyl)-6-methylpiperazine-2,5-dione|talathermophilin D

C24H29N3O3 (407.2209)

N-methylancistectorine A1

C25H29NO4 (407.2096)

Asperdiazapinone E

C23H25N3O4 (407.1845)

5,13-dihydroxy-2,4,6,14-tetramethyl-15-(2-methyl-1,3-thiazol-4-yl)pentadeca-10,14-dien-3-one

C23H37NO3S (407.2494)

13a-methyltylohirsutine

C25H29NO4 (407.2096)

Excelsine

C22H33NO6 (407.2308)

Norerythrostachaldid

C23H37NO5 (407.2672)

variecolorin C

C24H29N3O3 (407.2209)

4-(1,3-Dimethyl-6,8-dimethoxy-1,2,3,4-tetrahydroisoquinoline-5-yl)-6-methyl-8-methoxynaphthalene-1-ol

C25H29NO4 (407.2096)

Glabredelphinine

C22H33NO6 (407.2308)

Ancistrocladin

C25H29NO4 (407.2096)

6-O-methyl-4-O-demethylancistrocladine|6-O-methyl-4-O-demethylhamatine

C25H29NO4 (407.2096)

N-Cyano-sec-pseudobrucin

C24H29N3O3 (407.2209)

Alihirsutine A

C25H29NO4 (407.2096)

Glu Phe Ile

C20H29N3O6 (407.2056)

Asn Lys Phe

C19H29N5O5 (407.2169)

Asp Phe Leu

C20H29N3O6 (407.2056)

Leu Met Met

C17H33N3O4S2 (407.1912)

Phe Ile Glu

C20H29N3O6 (407.2056)

Lys Phe Asn

C19H29N5O5 (407.2169)

Val Leu Tyr

C21H33N3O5 (407.242)

Ile Tyr Ile

C21H33N3O5 (407.242)

phenylalanylasparagyllysine

C19H29N5O5 (407.2169)

Met Met Leu

C17H33N3O4S2 (407.1912)

Tyr Ile Ile

C21H33N3O5 (407.242)

Phe Glu Ile

C20H29N3O6 (407.2056)

Glu Ile Phe

C20H29N3O6 (407.2056)

Tyr Leu Val

C21H33N3O5 (407.242)

Leu Phe Asp

C20H29N3O6 (407.2056)

asparagylphenylalanyllysine

C19H29N5O5 (407.2169)

Leu Val Tyr

C21H33N3O5 (407.242)

Leu Asp Phe

C20H29N3O6 (407.2056)

Tyr Val Leu

C21H33N3O5 (407.242)

Ile Ile Tyr

C21H33N3O5 (407.242)

Asp Leu Phe

C20H29N3O6 (407.2056)

Leu Tyr Val

C21H33N3O5 (407.242)

Ile Glu Phe

C20H29N3O6 (407.2056)

Phe Asp Leu

C20H29N3O6 (407.2056)

Ile Phe Glu

C20H29N3O6 (407.2056)

Met Leu Met

C17H33N3O4S2 (407.1912)

Val Tyr Leu

C21H33N3O5 (407.242)

Phe Leu Asp

C20H29N3O6 (407.2056)

3-(4,6-dipyrrolidin-1-yl-1,3,5-triazin-2-yl)-1,2,3,4,5,6-hexahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one, 11-(4,6-dipyrrolidinyl-1,3,5-triazin-2-yl)-7,11-diazatricyclo[7.3.1.0<2,7>]tri deca-2,4-dien-6-one

3-(4,6-dipyrrolidin-1-yl-1,3,5-triazin-2-yl)-1,2,3,4,5,6-hexahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one, 11-(4,6-dipyrrolidinyl-1,3,5-triazin-2-yl)-7,11-diazatricyclo[7.3.1.0<2,7>]tri deca-2,4-dien-6-one

C22H29N7O (407.2433)

relative retention time with respect to 9-anthracene Carboxylic Acid is 0.968 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.973

SH407-1

C20H29N3O6 (407.2056)

Leucylleucyltyrosine

C21H33N3O5 (407.242)

1,5-dihydroxy-3-methoxy-10-methyl-2,4-bis(3-methylbut-2-enyl)acridin-9-one

NCGC00385825-01!1,5-dihydroxy-3-methoxy-10-methyl-2,4-bis(3-methylbut-2-enyl)acridin-9-one

C25H29NO4 (407.2096)

C22H33NO6_(5aS,9S,9aR)-9b-Hydroxy-6,6,9a-trimethyl-3-oxo-1,3,5,5a,6,7,8,9,9a,9b-decahydronaphtho[1,2-c]furan-9-yl N-acetylvalinate

NCGC00180730-03_C22H33NO6_(5aS,9S,9aR)-9b-Hydroxy-6,6,9a-trimethyl-3-oxo-1,3,5,5a,6,7,8,9,9a,9b-decahydronaphtho[1,2-c]furan-9-yl N-acetylvalinate

C22H33NO6 (407.2308)

C22H33NO6_Valine, N-acetyl-, 1,3,5,5a,6,7,8,9,9a,9b-decahydro-9b-hydroxy-6,6,9a-trimethyl-3-oxonaphtho[1,2-c]furan-9-yl ester

NCGC00381056-01_C22H33NO6_Valine, N-acetyl-, 1,3,5,5a,6,7,8,9,9a,9b-decahydro-9b-hydroxy-6,6,9a-trimethyl-3-oxonaphtho[1,2-c]furan-9-yl ester

C22H33NO6 (407.2308)

MMV020291

C21H33N3O3S (407.2243)

Monticoline

C22H33NO6 (407.2308)

Origin: Plant; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Aconitum alkaloid

(1S,4S,5S,6S,8S,9S,10S,13S,16S)-11-ethyl-6-methoxy-13-(methoxymethyl)-11-azahexacyclo(7.7.2.1(2,5).0(1,10).0(3,8).0(13,17))nonadecane-4,8,16-triol

C23H37NO5 (407.2672)

Origin: Plant; Formula(Parent): C23H37NO5; Bottle Name:Isotalatizidine; PRIME Parent Name:Isotalatizidine; PRIME in-house No.:V0317; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Aconitum alkaloid

Ala Cys Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]hexanamido]-3-hydroxypropanoic acid

C15H29N5O6S (407.1838)

Ala Cys Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]hexanoic acid

C15H29N5O6S (407.1838)

Ala Lys Cys Ser

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C15H29N5O6S (407.1838)

Ala Lys Ser Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C15H29N5O6S (407.1838)

Ala Ser Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]hexanoic acid

C15H29N5O6S (407.1838)

Ala Ser Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]hexanamido]-3-sulfanylpropanoic acid

C15H29N5O6S (407.1838)

Cys Ala Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]hexanamido]-3-hydroxypropanoic acid

C15H29N5O6S (407.1838)

Cys Ala Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-hydroxypropanamido]hexanoic acid

C15H29N5O6S (407.1838)

Cys Gly Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}hexanamido]-3-hydroxybutanoic acid

C15H29N5O6S (407.1838)

Cys Gly Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-hydroxybutanamido]hexanoic acid

C15H29N5O6S (407.1838)

Cys Lys Ala Ser

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]propanamido]-3-hydroxypropanoic acid

C15H29N5O6S (407.1838)

Cys Lys Gly Thr

(2S,3R)-2-{2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]acetamido}-3-hydroxybutanoic acid

C15H29N5O6S (407.1838)

Cys Lys Ser Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-hydroxypropanamido]propanoic acid

C15H29N5O6S (407.1838)

Cys Lys Thr Gly

2-[(2S,3R)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-hydroxybutanamido]acetic acid

C15H29N5O6S (407.1838)

Cys Ser Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]propanamido]hexanoic acid

C15H29N5O6S (407.1838)

Cys Ser Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]hexanamido]propanoic acid

C15H29N5O6S (407.1838)

Cys Thr Gly Lys

(2S)-6-amino-2-{2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]acetamido}hexanoic acid

C15H29N5O6S (407.1838)

Cys Thr Lys Gly

2-[(2S)-6-amino-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]hexanamido]acetic acid

C15H29N5O6S (407.1838)

Phe Gly Gly Lys

(2S)-6-amino-2-(2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}acetamido)hexanoic acid

C19H29N5O5 (407.2169)

Phe Gly Lys Gly

2-[(2S)-6-amino-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}hexanamido]acetic acid

C19H29N5O5 (407.2169)

Phe Lys Gly Gly

2-{2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]acetamido}acetic acid

C19H29N5O5 (407.2169)

Gly Cys Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]hexanamido]-3-hydroxybutanoic acid

C15H29N5O6S (407.1838)

Gly Cys Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-hydroxybutanamido]hexanoic acid

C15H29N5O6S (407.1838)

Gly Phe Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]acetamido}hexanoic acid

C19H29N5O5 (407.2169)

Gly Phe Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]hexanamido]acetic acid

C19H29N5O5 (407.2169)

Gly Gly Phe Lys

(2S)-6-amino-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-phenylpropanamido]hexanoic acid

C19H29N5O5 (407.2169)

Gly Gly Lys Phe

(2S)-2-[(2S)-6-amino-2-[2-(2-aminoacetamido)acetamido]hexanamido]-3-phenylpropanoic acid

C19H29N5O5 (407.2169)

Gly Lys Cys Thr

(2S,3R)-2-[(2R)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C15H29N5O6S (407.1838)

Gly Lys Phe Gly

2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-phenylpropanamido]acetic acid

C19H29N5O5 (407.2169)

Gly Lys Gly Phe

(2S)-2-{2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]acetamido}-3-phenylpropanoic acid

C19H29N5O5 (407.2169)

Gly Lys Thr Cys

(2R)-2-[(2S,3R)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C15H29N5O6S (407.1838)

Gly Thr Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-sulfanylpropanamido]hexanoic acid

C15H29N5O6S (407.1838)

Gly Thr Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]hexanamido]-3-sulfanylpropanoic acid

C15H29N5O6S (407.1838)

Leu Glu Phe

C20H29N3O6 (407.2056)

Leu Ile Tyr

C21H33N3O5 (407.242)

Phe Asn Lys

C19H29N5O5 (407.2169)

Tyr Ile Leu

C21H33N3O5 (407.242)

Phe Leu Glu

C20H29N3O6 (407.2056)

Lys Ala Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C15H29N5O6S (407.1838)

Lys Ala Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C15H29N5O6S (407.1838)

Lys Cys Ala Ser

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]propanamido]-3-hydroxypropanoic acid

C15H29N5O6S (407.1838)

Lys Cys Gly Thr

(2S,3R)-2-{2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]acetamido}-3-hydroxybutanoic acid

C15H29N5O6S (407.1838)

Lys Cys Ser Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]propanoic acid

C15H29N5O6S (407.1838)

Lys Cys Thr Gly

2-[(2S,3R)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]acetic acid

C15H29N5O6S (407.1838)

Phe Glu Leu

C20H29N3O6 (407.2056)

Glu Phe Leu

C20H29N3O6 (407.2056)

Lys Phe Gly Gly

2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]acetamido}acetic acid

C19H29N5O5 (407.2169)

Lys Gly Cys Thr

(2S,3R)-2-[(2R)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C15H29N5O6S (407.1838)

Lys Gly Phe Gly

2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-phenylpropanamido]acetic acid

C19H29N5O5 (407.2169)

Lys Gly Gly Phe

(2S)-2-(2-{2-[(2S)-2,6-diaminohexanamido]acetamido}acetamido)-3-phenylpropanoic acid

C19H29N5O5 (407.2169)

Lys Gly Thr Cys

(2R)-2-[(2S,3R)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C15H29N5O6S (407.1838)

Leu Tyr Leu

C21H33N3O5 (407.242)

Ile Tyr Leu

C21H33N3O5 (407.242)

Lys Ser Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]propanamido]-3-sulfanylpropanoic acid

C15H29N5O6S (407.1838)

Lys Ser Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]propanoic acid

C15H29N5O6S (407.1838)

Lys Ser Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C15H29N5O8 (407.2016)

Lys Thr Cys Gly

2-[(2R)-2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]acetic acid

C15H29N5O6S (407.1838)

Lys Thr Gly Cys

(2R)-2-{2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]acetamido}-3-sulfanylpropanoic acid

C15H29N5O6S (407.1838)

Leu Phe Glu

C20H29N3O6 (407.2056)

Leu Leu Tyr

C21H33N3O5 (407.242)

Tyr Leu Ile

C21H33N3O5 (407.242)

Phe Lys Asn

C19H29N5O5 (407.2169)

Glu Leu Phe

C20H29N3O6 (407.2056)

Ile Leu Tyr

C21H33N3O5 (407.242)

Tyr Leu Leu

C21H33N3O5 (407.242)

Lys Asn Phe

C19H29N5O5 (407.2169)

Ser Ala Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-sulfanylpropanamido]hexanoic acid

C15H29N5O6S (407.1838)

Ser Ala Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]hexanamido]-3-sulfanylpropanoic acid

C15H29N5O6S (407.1838)

Ser Cys Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]propanamido]hexanoic acid

C15H29N5O6S (407.1838)

Ser Cys Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]hexanamido]propanoic acid

C15H29N5O6S (407.1838)

Ser Lys Ala Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]propanamido]-3-sulfanylpropanoic acid

C15H29N5O6S (407.1838)

Ser Lys Cys Ala

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-sulfanylpropanamido]propanoic acid

C15H29N5O6S (407.1838)

Ser Lys Ser Ser

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C15H29N5O8 (407.2016)

Asn Phe Lys

C19H29N5O5 (407.2169)

Leu Tyr Ile

C21H33N3O5 (407.242)

Ser Ser Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]hexanamido]-3-hydroxypropanoic acid

C15H29N5O8 (407.2016)

Ser Ser Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]hexanoic acid

C15H29N5O8 (407.2016)

Thr Cys Gly Lys

(2S)-6-amino-2-{2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]acetamido}hexanoic acid

C15H29N5O6S (407.1838)

Thr Cys Lys Gly

2-[(2S)-6-amino-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]hexanamido]acetic acid

C15H29N5O6S (407.1838)

Thr Gly Cys Lys

(2S)-6-amino-2-[(2R)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-sulfanylpropanamido]hexanoic acid

C15H29N5O6S (407.1838)

Thr Gly Lys Cys

(2R)-2-[(2S)-6-amino-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}hexanamido]-3-sulfanylpropanoic acid

C15H29N5O6S (407.1838)

Thr Lys Cys Gly

2-[(2R)-2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]-3-sulfanylpropanamido]acetic acid

C15H29N5O6S (407.1838)

Thr Lys Gly Cys

(2R)-2-{2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]acetamido}-3-sulfanylpropanoic acid

C15H29N5O6S (407.1838)

Geranylgeranylcysteine

S-[(2E,6E,10E)-3,7,11,15-Tetramethyl-2,6,10,14-hexadecatetraenyl]- (9ci)-L-cysteine

C23H37NO3S (407.2494)

9b-Hydroxy-6,6,9a-trimethyl-3-oxo-1,3,5,5a,6,7,8,9,9a,9b-decahydronaphtho[1,2-c]furan-9-yl N-acetylvalinate

C22H33NO6 (407.2308)

18:3-Glu

N-(9Z,12Z,15Z-octadecatrienoyl)-glutamic acid

C23H37NO5 (407.2672)

Tinisulpride

C20H29N3O4S (407.1879)

Dextrorphan tartrate

C21H29NO7 (407.1944)

(R)-N-Fmoc-2-(7-octenyl)glycine

C25H29NO4 (407.2096)

Crystal Violet

C25H30ClN3 (407.2128)

D000890 - Anti-Infective Agents

(S)-N-Fmoc-2-(7-octenyl)glycine

C25H29NO4 (407.2096)

N-[[5-(dimethylamino)-1-naphthyl]sulphonyl]-L-alanine, compound with piperidine (1:1)

C20H29N3O4S (407.1879)

TRIS((1H-BENZO[D]IMIDAZOL-2-YL)METHYL)AMINE

C24H21N7 (407.1858)

R-(N-BENZYL-2-AMINO)-1-(4-METHOXYPHENYL)PROPANE (S)-MANDELIC ACID SALT

C25H29NO4 (407.2096)

fmoc-hocha-oh

C25H29NO4 (407.2096)

UNII:148K9U451A

C23H29N5O2 (407.2321)

Methanone, [4-(3,5-dimethoxyphenyl)-1-piperazinyl](5-methyl-3-phenyl-4-isoxazolyl)-

C23H25N3O4 (407.1845)

UNII:S831Z48C5W

Benproperine phosphate

C21H30NO5P (407.1862)

METHYL 3-(METHYLAMINO)-4-NITROBENZENECARBOXYLATE

C25H29NO4 (407.2096)

l-DROMORAN TARTRATE

C21H29NO7 (407.1944)

Crystal Violet Nonahydrate [Ion association reagent for spectrophotometric analysis]

C25H30ClN3 (407.2128)

S 14506

4-fluoro-N-[2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethyl]benzamide

C24H26FN3O2 (407.2009)

Boc-Ala-D-Glu(OBzl)-NH2

C20H29N3O6 (407.2056)

Amantocillin

C20H29N3O4S (407.1879)

2-Diethylaminoethyl hexanoate

C18H33NO9 (407.2155)

MPI-0479605

C22H29N7O (407.2433)

(S)-N-Fmoc-2-(6-heptenyl)alanine

C25H29NO4 (407.2096)

(S)-2-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)(Methyl)Amino)-3-Cyclohexylpropanoic Acid

C25H29NO4 (407.2096)

Alanine Valsartan

C22H25N5O3 (407.1957)

ciclonium bromide

C22H34BrNO (407.1824)

Tropodifene

C25H29NO4 (407.2096)

(R)-N-Fmoc-2-(6-heptenyl)alanine

C25H29NO4 (407.2096)

Paliroden

C26H24F3N (407.1861)

C26170 - Protective Agent > C1509 - Neuroprotective Agent

2-(4,6-Dimethylpyrimidin-2-yl)-5-((2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)carbonyl)octahydropyrrolo(3,4-C)pyrrole

C21H22FN7O (407.187)

C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

Seltorexant

C21H22FN7O (407.187)

Metrenperone

C24H26FN3O2 (407.2009)

C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist

3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oate

C24H39O5- (407.2797)

COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

(1S)-1,2,3,4-Tetrahydro-8-methoxy-1alpha,3beta-dimethyl-5-[(aR)-4,5-dimethoxy-2-methyl-1-naphthalenyl]isoquinoline-6-ol

C25H29NO4 (407.2096)

4-Methyl Erlotinib Hydrochloride

C23H25N3O4 (407.1845)

Cyclohexyl 2-cyano-2-[3-(4-ethylpiperazin-1-yl)quinoxalin-2-yl]acetate

C23H29N5O2 (407.2321)

L-Tyrosyl-L-isoleucyl-L-leucine

C21H33N3O5 (407.242)

L-Phenylalanyl-L-asparaginyl-L-lysine

C19H29N5O5 (407.2169)

7-Amino-2-Tert-Butyl-4-(4-Pyrimidin-2-Ylpiperazin-1-Yl)pyrido[2,3-D]pyrimidine-6-Carboxamide

C20H25N9O (407.2182)

(3Asr,4RS,8asr,8brs)-4-(2-(4-fluorobenzyl)-1,3-dioxodeacahydropyrrolo[3,4-A] pyrrolizin-4-YL)benzamidine

C23H24FN4O2+ (407.1883)

BIDISOMIDE

C22H34ClN3O2 (407.2339)

C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

Disobutamide

C23H38ClN3O (407.2703)

C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent

(9b-Hydroxy-6,6,9a-trimethyl-3-oxo-1,5,5a,7,8,9-hexahydrobenzo[e][2]benzofuran-9-yl) 2-acetamido-3-methylbutanoate

C22H33NO6 (407.2308)

3-[4,6-di(pyrrolidin-1-yl)-1,3,5-triazin-2-yl]-1,2,3,4,5,6-hexahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one

C22H29N7O (407.2433)

Ursocholate

C24H39O5- (407.2797)

A cholanic acid anion that is the conjugate base of ursocholic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

3beta,7alpha,12alpha-Trihydroxy-5beta-cholan-24-Oate

C24H39O5- (407.2797)

A bile acid anion that is the conjugate base of 3beta,7alpha,12alpha-trihydroxy-5beta-cholan-24-oic acid, obtained by deprotonation of the carboxy group. The 3beta-hydroxy epimer of cholate. It is the major microspecies at pH 7.3.

3alpha,7alpha,12beta-Trihydroxy-5beta-cholanate

C24H39O5- (407.2797)

A bile acid anion that is the conjugate base of 3alpha,7alpha,12beta-trihydroxy-5beta-cholanic acid, obtained by deprotonation of the carboxy group.

beta-Muricholate

C24H39O5- (407.2797)

Allocholate

C24H39O5- (407.2797)

A bile acid anion that is the conjugate base of allocholic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

alpha-Muricholate

C24H39O5- (407.2797)

3,5-Diprenylchalconaringenin

C25H27O5- (407.1858)

(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidin-1-ium-2-carboxamide

C18H35N2O6S+ (407.2216)

2-[(2E)-3,7-dimethylocta-2,6-dienyl]-3,5-dihydroxy-6-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]phenolate

C25H27O5- (407.1858)

(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-4-[hydroxy(methyl)phosphoryl]butanoyl]amino]propanoyl]amino]-4-methylpentanoic acid

C16H30N3O7P (407.1821)

N-Arachidonoyl Cysteine

C23H37NO3S (407.2494)

Talathermophilin D

C24H29N3O3 (407.2209)

A natural product found in Talaromyces thermophilus.

endiandramide B, rel-

C26H33NO3 (407.246)

A natural product found in Beilschmiedia tsangii.

20-Ethyl-16beta-methoxy-4-(methoxymethyl)aconitane-1alpha,8,14alpha-triol

C23H37NO5 (407.2672)

N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide

C20H33N5O4 (407.2532)

Pinnarine

C23H34ClNO3 (407.2227)

A natural product found in Halichondria okadai.

Phe-Leu-Glu

C20H29N3O6 (407.2056)

Ile-Ile-Tyr

C21H33N3O5 (407.242)

2-[5-[4-(dimethylamino)phenyl]-2-tetrazolyl]-N-[2-(4-morpholinyl)phenyl]acetamide

C21H25N7O2 (407.207)

N-butyl-3-[1-[(2,5-dimethylphenyl)methyl]-2,4-dioxo-3-quinazolinyl]propanamide

C24H29N3O3 (407.2209)

ethyl 4-(2,5-dimethylphenyl)-6-[[(4-methylphenyl)methylamino]methyl]-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxylate

C24H29N3O3 (407.2209)

[5-[(2-Methoxyphenoxy)methyl]-3-isoxazolyl]-(4-methyl-3-phenyl-1-piperazinyl)methanone

C23H25N3O4 (407.1845)

YIL zwitterion

C21H33N3O5 (407.242)

Compactin carboxylate

C23H35O6- (407.2434)

N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide

C20H33N5O4 (407.2532)

N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide

C20H33N5O4 (407.2532)

N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide

C20H33N5O4 (407.2532)

N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide

C20H33N5O4 (407.2532)

N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide

C20H33N5O4 (407.2532)

N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide

C20H33N5O4 (407.2532)

N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide

C20H33N5O4 (407.2532)

N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide

C20H33N5O4 (407.2532)

N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide

C20H33N5O4 (407.2532)

N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide

C20H33N5O4 (407.2532)

N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide

C20H33N5O4 (407.2532)

N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide

C20H33N5O4 (407.2532)

N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide

C20H33N5O4 (407.2532)

Leucyl-tyrosyl-leucine

C21H33N3O5 (407.242)

Glu-Ile-Phe

C20H29N3O6 (407.2056)

A tripeptide composed of L-glutamic acid, L-isoleucine and L-phenylalanine joined in sequence by peptide linkages.

Leu-Ile-Tyr

C21H33N3O5 (407.242)

Glu-Phe-Leu

C20H29N3O6 (407.2056)

Ile-Glu-Phe

C20H29N3O6 (407.2056)

Ile-Phe-Glu

C20H29N3O6 (407.2056)

Tyr-Leu-Leu

C21H33N3O5 (407.242)

Leucyl-glutamyl-phenylalanine

C20H29N3O6 (407.2056)

Asn-Phe-Lys

C19H29N5O5 (407.2169)

Lys-Asn-Phe

C19H29N5O5 (407.2169)

N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide

C20H33N5O4 (407.2532)

5-phenyl-3-[[(1R,5S)-7-(4-phenylphenyl)-3,6-diazabicyclo[3.1.1]heptan-6-yl]methyl]isoxazole

C27H25N3O (407.1998)

2-methoxy-N-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C21H33N3O5 (407.242)

(3S,6aR,8R,10aR)-3-hydroxy-N-(3-methoxyphenyl)-8-[2-(methylamino)-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide

C20H29N3O6 (407.2056)

3-fluoro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-pyrrolidinyl)ethylamino]ethyl]-3-oxanyl]benzamide

C21H30FN3O4 (407.222)

3-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-pyrrolidin-1-ylethylamino)ethyl]oxan-3-yl]benzamide

C21H30FN3O4 (407.222)

3-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-pyrrolidinyl)ethylamino]ethyl]-3-oxanyl]benzamide

C21H30FN3O4 (407.222)

(2R,3S)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(2-phenylethynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C24H29N3O3 (407.2209)

3-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-pyrrolidin-1-ylethylamino)ethyl]oxan-3-yl]benzamide

C21H30FN3O4 (407.222)

3-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-pyrrolidinyl)ethylamino]ethyl]-3-oxanyl]benzamide

C21H30FN3O4 (407.222)

(3R,9S,10S)-16-amino-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-13-one

C22H37N3O4 (407.2784)

(3S,9R,10R)-16-amino-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-13-one

C22H37N3O4 (407.2784)

(3R,9R,10R)-16-amino-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-13-one

C22H37N3O4 (407.2784)

(3R,9R,10R)-16-amino-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-13-one

C22H37N3O4 (407.2784)

(3S,9S,10S)-16-amino-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-13-one

C22H37N3O4 (407.2784)

2-methoxy-N-[(5S,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C21H33N3O5 (407.242)

2-methoxy-N-[(5S,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C21H33N3O5 (407.242)

2-methoxy-N-[(5S,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C21H33N3O5 (407.242)

3-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-pyrrolidinyl)ethylamino]ethyl]-3-oxanyl]benzamide

C21H30FN3O4 (407.222)

2-[(2R,5R,6S)-5-[[(cyclopentylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-fluorophenyl)methyl]acetamide

C21H30FN3O4 (407.222)

2-[(2R,5S,6S)-5-[[(cyclopentylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-fluorophenyl)methyl]acetamide

C21H30FN3O4 (407.222)

2-[(2S,5R,6R)-5-[[(cyclopentylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-fluorophenyl)methyl]acetamide

C21H30FN3O4 (407.222)

[(1S)-1-ethylsulfonyl-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol

C20H29N3O4S (407.1879)

[(2S,3S)-2-(hydroxymethyl)-1-(4-oxanylmethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-pyridin-4-ylmethanone

C24H29N3O3 (407.2209)

(3S,9S,10S)-16-amino-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-13-one

C22H37N3O4 (407.2784)

(3R,9S,10S)-16-amino-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-13-one

C22H37N3O4 (407.2784)

(3R,9S,10R)-16-amino-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-13-one

C22H37N3O4 (407.2784)

(3R,9S,10R)-16-amino-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-13-one

C22H37N3O4 (407.2784)

N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide

C20H33N5O4 (407.2532)

2-methoxy-N-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C21H33N3O5 (407.242)

2-methoxy-N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C21H33N3O5 (407.242)

2-methoxy-N-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C21H33N3O5 (407.242)

2-methoxy-N-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C21H33N3O5 (407.242)

2-methoxy-N-[(4R,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C21H33N3O5 (407.242)

2-methoxy-N-[(5R,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C21H33N3O5 (407.242)

2-methoxy-N-[(5R,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C21H33N3O5 (407.242)

2-methoxy-N-[(5S,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C21H33N3O5 (407.242)

2-methoxy-N-[(5R,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C21H33N3O5 (407.242)

3-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-pyrrolidinyl)ethylamino]ethyl]-3-oxanyl]benzamide

C21H30FN3O4 (407.222)

3-fluoro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-pyrrolidinyl)ethylamino]ethyl]-3-oxanyl]benzamide

C21H30FN3O4 (407.222)

2-[(2S,5R,6S)-5-[[(cyclopentylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-fluorophenyl)methyl]acetamide

C21H30FN3O4 (407.222)

2-[(2R,5S,6R)-5-[[(cyclopentylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-fluorophenyl)methyl]acetamide

C21H30FN3O4 (407.222)

2-[(2S,5S,6R)-5-[[(cyclopentylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-fluorophenyl)methyl]acetamide

C21H30FN3O4 (407.222)

2-[(2S,5S,6S)-5-[[(cyclopentylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-fluorophenyl)methyl]acetamide

C21H30FN3O4 (407.222)

2-[(2R,5R,6R)-5-[[(cyclopentylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-fluorophenyl)methyl]acetamide

C21H30FN3O4 (407.222)

(2R,3R,3aS,9bS)-N-cyclobutyl-3-(hydroxymethyl)-6-oxo-1-(2-phenylethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C24H29N3O3 (407.2209)

(2S,3S,3aR,9bR)-N-cyclobutyl-3-(hydroxymethyl)-6-oxo-1-(2-phenylethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C24H29N3O3 (407.2209)

[(1R)-1-ethylsulfonyl-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol

C20H29N3O4S (407.1879)

[(1S)-7-methoxy-2-[(3-methoxyphenyl)methyl]-1-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C24H29N3O3 (407.2209)

[(1R)-7-methoxy-2-[(3-methoxyphenyl)methyl]-1-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C24H29N3O3 (407.2209)

[(2S,3R)-2-(hydroxymethyl)-1-(4-oxanylmethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-pyridin-4-ylmethanone

C24H29N3O3 (407.2209)

(6R,7R,8R)-8-(hydroxymethyl)-7-[4-(4-methylphenyl)phenyl]-2-oxo-N-propan-2-yl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C24H29N3O3 (407.2209)

N-ethyl-N-[[(2S,3R,4S)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1-propylazetidin-2-yl]methyl]pyridine-2-carboxamide

C25H33N3O2 (407.2573)

2-Amino-5-[[1-[(1-carboxy-2-phenylethyl)amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid

C20H29N3O6 (407.2056)

Benzylpenicilloyl-butylamine

C20H29N3O4S (407.1879)

Phe-Glu-Ile

C20H29N3O6 (407.2056)

Asn-Lys-Phe

C19H29N5O5 (407.2169)

Glu-Phe-Ile

C20H29N3O6 (407.2056)

Ile-Tyr-Ile

C21H33N3O5 (407.242)

Phe-Glu-Leu

C20H29N3O6 (407.2056)

Phe-Ile-Glu

C20H29N3O6 (407.2056)

Tyr-Ile-Ile

C21H33N3O5 (407.242)

Ile-Leu-Tyr

C21H33N3O5 (407.242)

Ile-Tyr-Leu

C21H33N3O5 (407.242)

Glu-Leu-Phe

C20H29N3O6 (407.2056)

Leu-Phe-Glu

C20H29N3O6 (407.2056)

Leu-Tyr-Ile

C21H33N3O5 (407.242)

Lys-Phe-Asn

C19H29N5O5 (407.2169)

Phe-Lys-Asn

C19H29N5O5 (407.2169)

Tyr-Leu-Ile

C21H33N3O5 (407.242)

(S)-benproperine trihydrogen phosphate

C21H30NO5P (407.1862)

(R)-benproperine trihydrogen phosphate

C21H30NO5P (407.1862)

N-[(15S)-hydroperoxy-(5Z,8Z,11Z,13E)-icosatetraenoyl]alanine

C23H37NO5 (407.2672)

An N-acyl-L-alanine resulting from the formal condensation of the amino group of L-alanine with the carboxy group of (15S)-hydroperoxy-(5Z,8Z,11Z,13E)-icosatetraenoic acid.

N-[(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-icosatetraenoyl]alanine

C23H37NO5 (407.2672)

An N-acyl-L-alanine resulting from the formal condensation of the amino group of L-alanine with the carboxy group of (12S)-hydroperoxy-(5Z,8Z,10E,14Z)-icosatetraenoic acid.

4-(3-Chlorophenyl)-1-(2-hydroxy-3,3-diphenylpropyl)piperazin-1-ium(1+)

C25H28ClN2O+ (407.189)

(2S)-2-[4-(4-tert-butylphenyl)sulfonylpiperazin-1-yl]-1-pyrrolidin-1-ylpropan-1-one

C21H33N3O3S (407.2243)

(1S,5S,6S,8S,13R,16S,17R)-11-ethyl-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecane-4,8,16-triol

C23H37NO5 (407.2672)

Tetradecanal O-2,3,4,5,6-pentafluorobenzyloxime

C21H30F5NO (407.2247)

HexCer 9:0;2O/4:0

C19H37NO8 (407.2519)

HexCer 8:0;2O/5:0

C19H37NO8 (407.2519)

HexCer 10:0;2O/3:0

C19H37NO8 (407.2519)

HexCer 11:0;2O/2:0

C19H37NO8 (407.2519)

2-(Decanoylamino)-3-hydroxydecane-1-sulfonic acid

C20H41NO5S (407.2705)

(1alpha,5xi,9xi,10xi,14alpha)-20-Ethyl-16-methoxy-4-(methoxymethyl)aconitane-1,8,14-triol

C23H37NO5 (407.2672)

CerP 17:1;2O/2:0

C19H38NO6P (407.2437)

H-D-Leu-Leu-Tyr-OH

C21H33N3O5 (407.242)

Ancistrocladine

C25H29NO4 (407.2096)

1,3(2H,4H)-Isoquinolinedione, 2-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-4,4-dimethyl-

C24H29N3O3 (407.2209)

Leu-Leu-Tyr

Leucyl-leucyl-tyrosine

C21H33N3O5 (407.242)

Neurotensin 11-13

C21H33N3O5 (407.242)

N-linolenoyl glutamic acid

C23H37NO5 (407.2672)

NA-Cys 20:4(5Z,8Z,11Z,14Z)

C23H37NO3S (407.2494)

NA-DOPA 14:0

C23H37NO5 (407.2672)

NA-Glu 18:3(6Z,9Z,12Z)

C23H37NO5 (407.2672)

NA-Glu 18:3(9Z,12Z,15Z)

C23H37NO5 (407.2672)

NA-Met 18:4(6Z,9Z,12Z,15Z)

C23H37NO3S (407.2494)

Leu-Glu-Phe

C20H29N3O6 (407.2056)

Leu-Tyr-Leu

C21H33N3O5 (407.242)

Phe-Asn-Lys

C19H29N5O5 (407.2169)

ST 19:3;O5;Gly

C21H29NO7 (407.1944)

ST 20:2;O4;Gly

C22H33NO6 (407.2308)

ST 21:1;O3;Gly

C23H37NO5 (407.2672)

(1r,4e,6s,7s,11z)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate

C21H29NO7 (407.1944)

(1's,2s,2'r,3's,6's,11'r)-6'-hydroxy-11'-[(1r)-1-hydroxypropyl]-3-methoxy-3',4-dimethyl-10'-azaspiro[furan-2,5'-tricyclo[8.4.0.0²,⁶]tetradecane]-4',5-dione

C22H33NO6 (407.2308)

(3s,6s)-3-{[7,7-dimethyl-2-(2-methylbut-3-en-2-yl)-1h-chromeno[5,6-b]pyrrol-3-yl]methyl}-6-methyl-3,6-dihydropyrazine-2,5-diol

C24H29N3O3 (407.2209)

(1r,2r,3r,4s,5s,7s,8r,9s)-4-[3-(2h-1,3-benzodioxol-5-yl)propyl]-n-(2-methylpropyl)tetracyclo[5.4.0.0²,⁵.0³,⁹]undec-10-ene-8-carboximidic acid

C26H33NO3 (407.246)

4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate

C21H29NO7 (407.1944)

(1s,2r,3r,4r,5s,6s,8s,9s,10r,13r,16s,17s)-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-ene-4,8,12-triol

C22H33NO6 (407.2308)

11-ethyl-13-(hydroxymethyl)-6,8-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,16-diol

C23H37NO5 (407.2672)

(1r,3s)-7-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-8-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-6-ol

C25H29NO4 (407.2096)

(1s,2r,3s,4s,5r,6s,8s,9s,10r,13s,16s,17r)-11-ethyl-13-(hydroxymethyl)-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8-diol

C23H37NO5 (407.2672)

(1s,3s)-5-(4,5-dimethoxy-7-methylnaphthalen-1-yl)-8-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-6-ol

C25H29NO4 (407.2096)

5-hydroxy-3-{[7-(4-hydroxy-3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6-methyl-1,6-dihydropyrazin-2-one

C24H29N3O3 (407.2209)

(1r,4z,6s,7s,11z)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate

C21H29NO7 (407.1944)

(1s,5s,6s,8s,9s,13s,16s)-11-ethyl-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,16-triol

C23H37NO5 (407.2672)

(1s,2s,3s,4s,5r,6r,8r,9s,10r,13s,16s,17r)-11-ethyl-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,16-triol

C23H37NO5 (407.2672)

(1s,2r,3r,4s,5s,6s,8s,9s,10r,13s,16s,17r)-11-ethyl-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,16-triol

C23H37NO5 (407.2672)

(1r,3r)-5-(4-hydroxy-5-methoxy-7-methylnaphthalen-1-yl)-6-methoxy-1,2,3-trimethyl-3,4-dihydro-1h-isoquinolin-8-ol

C25H29NO4 (407.2096)

(1s,2r,3r,4s,5s,6s,8s,9s,10r,13s,16s,17r)-11-ethyl-13-(hydroxymethyl)-6,8-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,16-diol

C23H37NO5 (407.2672)

3-{[1-carboxy-2-(3h-imidazol-4-yl)ethyl]amino}-2-{[1-hydroxy-3-(3h-imidazol-4-yl)-2-(methylamino)propylidene]amino}butanoic acid

C17H25N7O5 (407.1917)

ancistrobertsonine D

C25H29NO4 (407.2096)

{"Ingredient_id": "HBIN015986","Ingredient_name": "ancistrobertsonine D","Alias": "NA","Ingredient_formula": "C25H29NO4","Ingredient_Smile": "CC1CC2=CC(=C(C(=C2C(N1)C)OC)C3=C4C=CC=C(C4=C(C=C3C)OC)OC)O","Ingredient_weight": "407.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35976","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10476498","DrugBank_id": "NA"}

ancistrobrevine b

C25H29NO4 (407.2096)

{"Ingredient_id": "HBIN015988","Ingredient_name": "ancistrobrevine b","Alias": "NA","Ingredient_formula": "C25H29NO4","Ingredient_Smile": "CC1CC2=C(C(=CC(=C2C(N1)C)OC)O)C3=C4C=C(C=C(C4=C(C=C3)OC)OC)C","Ingredient_weight": "407.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "19529;21541","PubChem_id": "11015040","DrugBank_id": "NA"}

ancistrotanzanine c

C25H29NO4 (407.2096)

{"Ingredient_id": "HBIN015998","Ingredient_name": "ancistrotanzanine c","Alias": "NA","Ingredient_formula": "C25H29NO4","Ingredient_Smile": "CC1CC2=CC(=C(C(=C2C(N1C)C)OC)C3=C(C4=C(C=CC=C4OC)C=C3C)O)O","Ingredient_weight": "407.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1147","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11350305","DrugBank_id": "NA"}